DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Anderson MG, Zhang Q, Rodriguez LE. et al.
ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition.
BMC Cancer 2021;
21 (01) 681
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.